<

 
Data updated 2025-05-28 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date02802898.3 (espacenet)  (Federated)  (European Patent Register), 20021108
Patent/reg. no. and dateDK/EP 1476185, 20130731
Publication date20041117
Priority no. and dateUS 348980 P, 20011109
EP pub. no. and date EP 1476185 20041117
Effective date
Applicant/ownerPfizer Products Inc., Eastern Point Road
Groton, CT 06340, US,
Amgen Fremont Inc., One Amgen Center Drive
Thousand Oaks, CA 91320-1799, US
Applicant ref. no.NGC/GP/147531
InventorBEDIAN, Vahe, 3 Frog Hollow Road
East Lyme, CT 06333, US,
GLADUE, Ronald, P., 83 Rowley Drive
Stonington, CT 06378, US,
CORVALAN, Jose, 125 Williams lane
Foster City, CA 94404, US,
FENG, Xiao, 135 Red Cedar Lane
Union City, CA 94587, US,
JIA, Xiao-Chi, 22 Murray Court
San Mateo, CA 94403, US
RepresentativeBudde Schou A/S, Dronningens Tværgade 30, 1302 København K
Opponent
IPC ClassA61K 39/395 (2006.01) , C07K 16/28 (2006.01) , C12N 15/00 (2006.01) , C12N 15/11 (2006.01) , C12N 15/12 (2006.01) , C12N 15/63 (2006.01) , C12N 5/10 (2006.01) 
TitleAntistoffer mod CD40
Int. application no.US2002036107
Int. publication no.WO2003040170
Related patent (certificate)
StatusUdløbet
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact